COVID-19 Makes the Reinvigoration of American Manufacturing a National-Security Concern

A nurse works at a drive-thru coronavirus testing site at North Shore University Hospital in Manhasset, N.Y., May 6, 2020. (Brendan McDermid/Reuters)
Fortunately, an existing government entity provides a model for repatriating the production of medical supplies and other key products.

NRPLUS MEMBER ARTICLE T he coronavirus pandemic has once more put the dark side of globalization in the spotlight. On both sides of the aisle, there is an increasing sense that, in its current form, globalization has resulted in an over-reliance on Chinese-made goods at the expense of domestic manufacturing capacity. Senator Marco Rubio recently cited the need for “a 21st-century, pro-American industrial policy,” warning that “the depletion of America’s manufacturing sector has left us with a huge national-security vulnerability.” Senator Elizabeth Warren likewise offered vocal support for legislation aimed at limiting the quantity of Chinese-made pharmaceuticals in the United States’ drug supply. As

To Read the Full Story


The Latest